News
IQV
227.40
-1.88%
-4.36
Agree To Buy IQVIA Holdings At $175, Earn 3.7% Using Options
NASDAQ · 3d ago
How Is The Market Feeling About IQVIA Hldgs?
Benzinga · 3d ago
Teva launches first U.S. generic against Novartis antidiarrheal Sandostatin LAR
Seeking Alpha · 3d ago
Weekly Report: what happened at IQV last week (0923-0927)?
Weekly Report · 4d ago
Is Viking Therapeutics Stock a Buy?
The Motley Fool · 5d ago
Wednesday Sector Laggards: Energy, Healthcare
NASDAQ · 09/25 18:59
Medpace, Fortrea cut as Jefferies reviews CROs amid biotech headwinds
Seeking Alpha · 09/25 13:01
Truist Financial Gives a Buy Rating to IQVIA Holdings (IQV)
TipRanks · 09/24 11:26
Veeva Systems: SMB Sector Is Growing Momentum
Seeking Alpha · 09/24 10:42
Overweight quality stocks with positive EPS revision - MS
Seeking Alpha · 09/23 20:17
Stocks that are expected to benefit from lower fed funds rate and a softer labor market
Seeking Alpha · 09/23 15:20
Is Charles River Laboratories Stock Underperforming the Dow?
Barchart · 09/23 11:02
Weekly Report: what happened at IQV last week (0916-0920)?
Weekly Report · 09/23 09:16
Tracking William Nygren's Harris Associates Portfolio - Q2 2024 Update
Seeking Alpha · 09/23 00:14
IQVIA Holdings Inc.'s (NYSE:IQV) Business Is Trailing The Market But Its Shares Aren't
Simply Wall St · 09/22 12:11
A Closer Look at 13 Analyst Recommendations For IQVIA Hldgs
Benzinga · 09/20 12:00
IQVIA Holdings Price Target Raised to $256.00/Share From $251.00 by Baird
Dow Jones · 09/20 11:25
IQVIA Holdings Is Maintained at Neutral by Baird
Dow Jones · 09/20 11:25
Baird Maintains Neutral on IQVIA Hldgs, Raises Price Target to $256
Benzinga · 09/20 11:15
ICON draws bullish view at Leerink on business model
Seeking Alpha · 09/18 19:28
More
Webull provides a variety of real-time IQV stock news. You can receive the latest news about Iqvia Hldgs Inc through multiple platforms. This information may help you make smarter investment decisions.
About IQV
IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Its segments include Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment offers mission-critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions segment serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment offers health care providers (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market. Its Connected Intelligence delivers insights and solutions enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients.